A Phase II Study of UCN-01 in Metastatic Melanoma

NCT00072189 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

NIH

Sponsor class

Stopped Early termination for discouraging results

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

DRUG: 7-hydroxystaurosporine
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)